Clear all

Refine your search

Content type
Tags
Firm name
Author
Jurisdiction
Language

1,556 results found

Analysis PRO In-house
Ask Lexy

Lexology PRO | USA | 14 Apr 2021

Imposing a monitor is “very fact-dependent”, says SEC official

A senior SEC enforcement official said it’s often a challenge for government lawyers to determine whether to impose a compliance monitor on a company.
Lexology Learn videos PRO

Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021

How compliance games boost business engagement

Rafael Ferri, legal director at Novartis (Brazil), looks back at his experiments with gamification to boost compliance-business engagement while working as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology Learn videos PRO

Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021

How to increase business-compliance engagement

Rafael Ferri, legal director at Novartis (Brazil), discusses the best practices to boost compliance-business engagement that he used while working as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology Learn videos PRO

Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021

How to facilitate business-compliance engagement during COVID-19

Rafael Ferri, legal director at Novartis (Brazil), discusses the best practices he used to boost compliance-business engagement during the COVID-19 pandemic in his role as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Analysis PRO In-house
Ask Lexy

PRO Compliance | European Union, France, Italy, etc. | 22 Jan 2021

Novartis and Roche ordered to pay €30.9 million cartel fine

The Turkish Competition Authority has become the latest enforcer to fine pharmaceutical companies Novartis and Roche for colluding to exaggerate a drug's potential side effects to encourage users to purchase a more expensive one.
Analysis PRO In-house
Ask Lexy

PRO Compliance | European Union, Greece | 11 Nov 2020

Greece merges major enforcement agencies

Greece has joined its anti-corruption and financial crime authorities in an attempt to strengthen and streamline enforcement.
Analysis PRO In-house
Ask Lexy

PRO Compliance | Global, USA | 3 Nov 2020

SEC has record enforcement year despite pandemic challenges

The agency’s annual report highlights its record enforcement numbers, its likely response to a Supreme Court ruling limiting its disgorgement powers, a significant uptick in whistleblower payouts and the agency’s first virtual trial amid the coronavirus pandemic.
Article
Ask Lexy

Skadden Arps Slate Meagher & Flom LLP | USA | 24 Aug 2020

Novartis’ $678 Million Settlement Sets Guideposts for Life Sciences Industry Speaker Programs

Novartis Pharmaceuticals Corporation1 (Novartis) recently entered into a civil settlement agreement with the Department of Justice (DOJ) to resolve…
Analysis PRO In-house
Ask Lexy

PRO Compliance | China, Greece, USA | 25 Jun 2020

Novartis, Alcon pay $347 million to settle FCPA case

Two former FCPA unit chiefs guided Novartis and Alcon to foreign bribery settlements over schemes to increase sales by paying off healthcare professionals.
Article
Ask Lexy

Loeb & Loeb LLP | USA | 5 Jun 2020

Novartis, Alcon to Pay $345 M to Resolve FCPA Matters

Novartis Hellas S.A.C.I. (Novartis Greece), a subsidiary of Novartis AG, a Switzerland-based global pharmaceutical company, and Alcon Pte Ltd., a…
Previous page 1 2 3 ...